Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech News Today.
Press releases published on October 21, 2025
Eos Energy Executes Next Phase of Growth Strategy with U.S. Manufacturing Expansion and New Software Hub Under Project AMAZE
$24 million state-led economic development package underscores the shared commitment between Eos and Pennsylvania to advance U.S. manufacturing and job creation Expansion reinforces the Company’s progress and transformation as Pennsylvania becomes a …
HII Increases Quarterly Dividend to $1.38 per Share
NEWPORT NEWS, Va., Oct. 21, 2025 (GLOBE NEWSWIRE) -- HII (NYSE: HII) announced today that its Board of Directors has declared a quarterly cash dividend of $1.38 per share, a $0.03 increase over the $1.35 per share dividend paid in each of the prior four …
Microchip Adds Highly Integrated Single-Chip Wireless Platform Designed for Advanced Connectivity, Touch and Motor Control
CHANDLER, Ariz., Oct. 21, 2025 (GLOBE NEWSWIRE) -- As connectivity standards and market needs evolve, upgradeability has become essential for extending device lifecycles, minimizing redesigns and enabling differentiated features. To solve this challenge, …
Elate Launches Strategy Advisor, an AI-Built System for Strategy Execution
INDIANAPOLIS, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Elate, the strategy platform built for Strategy and Operations leaders, today announced the public launch of Strategy Advisor, the first domain-specific AI designed to transform how organizations plan, align, …
MediBeacon receives regulatory approval to sell the Transdermal GFR System in China
MediBeacon® Transdermal GFR System (TGFR) is a first-in-kind product for point of care assessment of kidney function in patients with normal or impaired renal function The TGFR will be available for sale in China before the end of the year NEW YORK, Oct. …
ModelOp Releases Landmark Whitepaper “Preparing for Agentic AI” that Urges Enterprises to Establish Control with Its Practical Roadmap to Avoid Catastrophic Risk Exposure
CHICAGO, Oct. 21, 2025 (GLOBE NEWSWIRE) -- ModelOp, the leader in AI lifecycle management and governance software for the enterprise, today announced the release of its new whitepaper, “The Enterprise’s Guide to Preparing for Agentic AI.” The report warns …
Douglas Dynamics Announces Third Quarter 2025 Earnings Release and Conference Call
MILWAUKEE, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Douglas Dynamics, Inc. (NYSE: PLOW), North America's premier manufacturer and upfitter of work truck attachments and equipment, today announced that it will release financial results for the third quarter of …
Ferroglobe PLC Schedules Third Quarter 2025 Earnings Call for November 6, 2025
LONDON, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Ferroglobe PLC (NASDAQ: GSM) announced today that it will issue third quarter 2025 financial results after the market closes on Wednesday, November 5, 2025, and will host the quarterly earnings call on Thursday, …
Krystal Biotech to Report Third Quarter 2025 Financial Results on November 3, 2025
PITTSBURGH, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) announced today that it will report its third quarter 2025 financial results on Monday, November 3, 2025, prior to the open of U.S. markets. The Company’s …
Soleno Therapeutics to Report Third Quarter 2025 Financial Results on November 4, 2025, at 4:30 PM ET
REDWOOD CITY, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that it will report its third quarter …
IPG Photonics to Announce Third Quarter 2025 Financial Results on November 4
MARLBOROUGH, Mass., Oct. 21, 2025 (GLOBE NEWSWIRE) -- IPG Photonics Corporation (Nasdaq: IPGP) will release its third quarter 2025 financial results before the market opens on Tuesday, November 4, 2025. The Company will hold a conference call to review …
Avalyn Announces Multiple Presentations at the Pulmonary Fibrosis Foundation (PFF) Summit 2025
BOSTON, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on the development of inhaled therapies for the treatment of life-threatening pulmonary diseases, today announced multiple presentations at the …
New Book by Matthew Chang Premieres “Risk-Taking Is Biblical,” Exploring the Intersection of Faith, Innovation, and Leadership
JACKSONVILLE, Fla., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Chang Robotics today announced the release of “Risk-Taking Is Biblical,” the debut book by company founder and principal engineer Matthew Chang. The new book is now available worldwide and explores the …
Ardelyx Announces Four Abstracts Accepted for Poster Presentations at the American Society of Nephrology’s Kidney Week
WALTHAM, Mass., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today …
Rocket Doctor Expands U.S. Coverage, Becoming In-Network with Two Leading National Insurers With More Than 6.5 Million Additional Members Across California and New York State
These new agreements include approximately 2.7 million members in California under one major insurer and 3.8 million members in New York under two major insurers, extending Rocket Doctor’s total in-network reach to over 13 million members nationwide. This …
Cidara Therapeutics Announces Late-Breaking Phase 2b Data Presentation on CD388 at ID Week 2025
SAN DIEGO, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company applying its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced it presented late-breaking Phase …
Mineralys Therapeutics Announces Late-Breaking Presentation of Phase 2 Explore-CKD Trial of Lorundrostat at American Society of Nephrology (ASN) Kidney Week 2025
~ Late-breaking Phase 2 trial data evaluating the safety and efficacy of 25 mg of lorundrostat in participants with hypertension and comorbid CKD to be presented~ ~ Phase 3 data of the Launch-HTN Trial of lorundrostat to be included in “Best of Journal of …
authID Selected by Leading Global Retailer to Launch Biometric-Powered Digital Identity Verification and Password Reset System
DENVER, Oct. 21, 2025 (GLOBE NEWSWIRE) -- authID (Nasdaq: AUID) (“authID” or the “Company”), a leading provider of biometric identity verification and authentication solutions, today announced that one of the largest retailers in Europe (the “Customer”), …
DMC Global Schedules Third Quarter Earnings Release and Conference Call
BROOMFIELD, Colo., Oct. 21, 2025 (GLOBE NEWSWIRE) -- DMC Global Inc. (Nasdaq: BOOM) will announce its 2025 third quarter financial results after the stock market closes on Tuesday, November 4, 2025. Following the earnings release, executive management will …